1 Gifford D (2002) Dietary Fats, Eating Guides and Public Policy: History, Critique, and Recommendations. Am J Med 113, 89S–106S, .
2 Kritchevsky D (1998) History of Recommendations to the Public about Dietary Fat. J Nutr 128, 449S–452S.
3 Committee on Medical Aspects of Food Policy (COMA) (1991) Dietary Reference Values (DRVs) for Food Energy and Nutrients for the UK. Report on Health and Social Subjects 41. London: The Stationary Office.
4 Yates AA (1998) Overview of Key Nutrients: Energy and Macronutrient Aspects. Nutr Rev 56, S29–S33.
5 Institutes of Medicine (IOM) (2002/2005) .
6 FAO (1994) Fats and oils in human nutrition. Rome: FAO.
7 WHO-FAO (2003) Diet, nutrition and the prevention of chronic diseases. Geneva: WHO.
8 FAO-WHO (2010) Fats and Fatty Acids in Human Nutrition. Rome: FAO Food and nutrition paper # 91. .
9 Smit LA, Mozaffarian D & Willett W (2009) Review of Fat and Fatty Acid Requirements and Criteria for Developing Dietary Guidelines. Ann Nutr Metab 55, 44–55.
10 Moher D, Liberati A, Tetzlaff J & Altman DG, (2009) Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6, .
11 Systematic Reviews Collaborative Tool (SysCollab) [Computer program] (2010). .
12 ISSFAL, International Society for the Study of Fatty Acids and Lipids (2004) Report of the Sub-Committee on Recommendations for intake of polyunsaturated fatty acids in healthy adults. ISSFAL: Brighton, UK.
13 Koletzko B, Lien E, Agostoni C, et al. (2008) The roles of longchain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
14 American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
15 Harris WS, Mozaffarian D, Rimm E, et al. (2009) Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119, 902–907.
16 Anderson GH & Zlotkin SH (2000) Developing and implementing food-based dietary guidance for fat in the diets of children. Am J Clin Nutr 72, Suppl, 1004S–1009S.
17 Gidding SS, Dennison BA, Birch LL, et al. (2006) Dietary Recommendations for Children and Adolescents: A Guide for Practitioners. Pediatrics 117, 544.
18 U.S. Department of Agriculture, U.S. Department of Health and Human Services (2010) Dietary Guidelines for Americans, 2010, 7th Edition Washington, DC: U.S. Government Printing Office, December.
19 EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA) (2010) Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. The EFSA Journal 8, 1461.
20 Fourth Joint Task Force of the European Society of Cardiology (2007) European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehab 14, suppl 2, S1–S113.
21 Doets EL, de Wit LS, Dhonukshe-Rutten RAM, et al. (2008) Current micronutrient recommendations in Europe: towards understanding their differences and similarities. Eur J Nutr 47, Suppl. 1, 17–40.
22 Pavlovic M, Prentice A, Thörsdottir I, et al. (2007) Challenges in Harmonizing Energy and Nutrient Recommendations in Europe. Ann Nutr Metab 51, 108–114.
24 Iglesia I, Doets EL, Bel-Serrat S, et al. (2010) Physiological and public health basis for assessing micronutrient requirements in children and adolescents. The EURRECA network. Maternal & Child Nutr 6, 84–99.
25 Kris-Etherton PM & Innis S (2007) Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 107, 1599–1611.
26 American Diabetes Association (2008) Nutrition Recommendations and Interventions for Diabetes. A position statement of the American Diabetes Association. Diabetes Care 31, Suppl, S61–S78.
27 Ferroluzzi A & James WPT (2001) European diet and public health: The continuing challenge. Public Health Nutr 4, 2A 275–292.
28 DACH (2002) German Nutrition Society (Dge). Austrian Nutrition Society (Öge); Referenzwerte Für Die Nährstoffzufuhr/Reference Values For Nutrient Intake. Umschau/Braus: Frankfurt/Main.
29 Gezondheidsraad; Health Council of the Netherlands (2002) Dietary reference intakes. Energy, proteins, fats, and digestible carbohydrates. The Hague, NL: The Health Council of the Netherlands.
30 Health Council of the Netherlands (2006) Guidelines to a healthy diet 2006. The Hague: Health Council of the Netherlands: publication no: 2006/21E.
31 Martin A (Editor) (2001) Apports nutritionnels conseilles pour la population Française, 3rd ed. France: Tech. & Doc Lavoisier.
32 Conseil Supérieur de la Santé (2009) .
33 Becker W, Lyhne N, Pedersen AN, et al. (2004) Nordic Nutrition Recommendations 2004/integrating nutrition and physical activity. Scan J Nutr 48, 178–187.
34 Aranceta J, Serra Majem Ll, Grupo Colaborativo para la actualización de los Objetivos Nutricionales para la Población Española (2011). 17, 178–199.
35 National Health and Medical Research Council, Department of Health and Ageing (2006) .
36 Jang YA, Lee HS, Kim BH, et al. (2008) Revised dietary guidelines for Koreans. Asia Pac J Clin Nutr 17, S1yes, 55–58.
37 A Report of the Expert Group of the Indian Council Of Medical Research (2009) .
38 Alasfoor D, Rajab H, Al-Rassas B, et al. (2009) Oman Food Based Dietary Guidelines Technical background and description. .
39 Bray GA & Popkin BM (1998) Dietary fat intake does affect obesity! Am J Clin Nutr 68, 1157–1173.
40 Elmadfa I & Kornsteiner M (2009) Fats and Fatty Acid Requirements for Adults. Ann Nutr Metab 55, 56–75.
41 Uauy R (2009) Dietary Fat Quality for Optimal Health and Well-Being: Overview of Recommendations. Ann Nutr Metab 54, Suppl. 1, 2–7.
42 Marantz PR, Bird ED & Alderman MH (2008) A Call for Higher Standards of Evidence for Dietary Guidelines. Am J Prev Med 34, 234–240.
43 World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington: WCRF/AICR.
44 Nordmann AJ, Nordmann A, Briel M, et al. (2006) Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 166, 285–293.
45 Howard BV, Van Horn L, Hsia J, et al. (2006) Low-Fat Dietary Pattern and Risk of Cardiovascular Disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295, 655–666.
46 Melanson EL, Astrup A & Donahoo WT (2009) The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome. Ann Nutr Metab 55, 229–243.
47 Krauss RM, Eckel RH, Howard B, et al. (2000) AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association. Circulation 102, 2284–2299.
48 Kris-Etherton P, Daniels SR, Eckel RH, et al. (2001) AHA Scientific Statement: Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. J Nutr 131, 1322–1326.
49 Hu FB & Willet W (2002) Optimal Diets for Prevention of Coronary Heart Disease. JAMA 288, 2569–2578.
50 Wahrburg U (2004) What are the health effects of fat? Eur J Nutr 43, Suppl. 1, I/6–I/11.
51 Gebauer SK, Psota TL, Harris WS, et al. (2006) n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, Suppl, 1526S–1535S.
52 Kok FJ & Kromhout D (2004) Atherosclerosis. Epidemiological studies on the health effects of a Mediterranean diet. Eur J Nutr 43, Suppl 1, I/2–I/5.
53 Wahlqvist ML (2005) Dietary fat and the prevention of chronic disease. Asia Pac J Clin Nutr 14, 313–318.
54 German D (2004) Saturated fats: what dietary intake? Am J Clin Nutr 80, 550–559.
55 Mann JI (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360, 783–789.
56 Mensink RP, Zock PL, Kester AD, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
57 Sacks FM & Katan M (2002) Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 11, Suppl 9B, 13S–24S.
58 Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. (2009) Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89, 1425–1432.
59 Skeaff CM & Miller J (2009) Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomized controlled trials. Ann Nutr Metab 55, 173–201.
60 Mozaffarian D (2005) Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med 11, 24–30, .
61 Mozaffarian D & Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885–1899.
62 Akabas SR & Deckelbaum RJ (2006) Summary of a workshop on n_3 fatty acids: current status of recommendations and future directions. Am J Clin Nutr 83, Suppl, 1536S–1538S.
63 Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71, Suppl, 171S–175S.
64 Harris WS, Mozaffarian D, Lefevre M, et al. (2009) Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids. J Nutr 139, 804S–819S.
65 Hooper L, Thompson RL, Harrison RA, et al. (2006) Risk and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: a systematic review. BMJ .
66 Horrocks LA & Yeo YK (1999) Health benefits of Docosahexaenoic acid (DHA). Pharmacol Res 40, 211–225.
67 Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl, 560S–569S.
68 Simopoulos AP (2001) n-3 Fatty Acids and Human Health: Defining Strategies for Public Policy. Lipids 36, S83–S89.
69 GISSI-HF Investigators (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223–1230.
70 Brenna JT (2009) Background Paper on Fat and Fatty Acid Requirements during Pregnancy and Lactation. Ann Nutr Metab 55, 97–122.
71 Koletzko B, Cetin I & Brenna JT, (2007) Consensus Statement. Dietary fat intakes for pregnant and lactating women. Br J Nutr 98, 873–877.
72 Koletzko B, Uauy R, Palou A, et al. (2010) Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report. Br J Nutr 103, 923–928.
73 Lapillonne A & Jensen CL (2009) Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids 81, 143–150.
74 Le H, Meisel JA, deMeijer VE, et al. (2009) The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 81, 165–170.
75 Makrides M (2009) Is there a dietary requirement for DHA in pregnancy? Prostaglandins Leukot Essent Fatty Acids 81, 171–174.
76 Prentice A, Branca F, Decsi T, et al. (2004) Energy and nutrient dietary reference values for children in Europe: methodological approaches and current nutritional recommendations. Br J Nutr 92, Suppl. 2, S83–S146.
77 Uauy R & Dangour AD (2009) Fat and Fatty Acid Requirements and Recommendations for Infants of 0–2 Years and Children of 2–18 Years. Ann Nutr Metab 55, 76–96.
78 Gil-Campos M, (2010) Importancia del ácido docosahexaenoico (DHA): funciones y recomendaciones para su ingesta en la infancia. An Pediatr (Barc) 73, 142e1–142e8.
79 Wolfram G (Ed.) (2005) The Nutrition Report 2004. Summary. Bonn: German Nutrition Society/Deutsche Gesellschaft für Ernährung e.V.
80 Czernichow S, Thomas D & Bruckert E (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104, 788–796.
81 Ramsden CE, Hibbeln JR, Majchrzak SF, et al. (2010) n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomized controlled trials. Br J Nutr 104, 1586–1600.
82 Calder PC & Deckelbaum RJ (2011) Harmful, harmless or helpful? The n-6 fatty acid debate goes on. Curr Opin Clin Nutr Metab Care 14, 113–114.
83 Deckelbaum RJ & Calder PC (2010) Dietary n-3 and n-6 fatty acids: are there ‘bad’ polyunsaturated fatty acids? Curr Opin Clin Nutr Metab Care 13, 123–124.
84 Molendi-Coste O, Legry V & Leclercq IA (2011) Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract, .
85 Kris-Etherton PM, Grieger JA & Etherton TD (2009) Dietary reference intakes for DHA and EPA. Prostaglandins, Leukot Essent Fatty Acids 81, 99–104.
86 Wang C, Harris WS, Chung Mn-3, et al. (2006) Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
87 Ness AR, Hughes J, Elwood PC, et al. (2002) The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction Trial (DART). Eur J Clin Nutr 56, 512–518.
88 Yokoyama M, Origasa H, Matsuzaki M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
89 Marik PE & Varon J (2009) Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review. Clin. Cardiol 32, 7, 365–372.
90 Burr ML, Dunstan FDJ & George CH (2005) Is Fish Oil Good or Bad for Heart Disease? Two Trials with Apparently Conflicting Results. J. Membrane Biol. 206, 155–163.
91 Rauch B, Schiele R, Schneider S, et al. (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122, 21, .
92 Kromhout D, Giltay EJ & Geleijnse JMfor the Alpha Omega Trial Group (2010) n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction. N Engl J Med 363, 2015–2026.
93 Filion KB, El Khoury F, Bielinski M, et al. (2010) Omega- 3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 10, 24.
94 Nodari S, Triggiani M, Campia U, et al. (2011) n-3 Polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion. A prospective, randomized study. Circulation 124, .
95 Liu T, Korantzopoulos P, Shehata M, et al. (2011) Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 97, 13,
96 Crawford MA, Bazinet RP & Sinclair AJ (2009) Fat intake and CNS functioning: ageing and disease. Ann Nutr Metab 55, 202–228.
97 Kornsteiner M, Singer I & Elmadfa I (2008) Very low n-3 long-chain polyunsaturated fatty acid status in Austrian vegetarians and vegans. Ann Nutr Metab 52, 37–47.
98 Joint FAO/WHO Expert Consultation on the Risks and Benefits of Fish Consumption. .
99 Food and Drug Administration, Environmental Protection Agency (2004) What you need to know about mercury in fish and shellfish. Washington, DC, .
100 Wijendran V & Hayes KC (2004) Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24, 597–615.
101 Burdge GC & Calder PC (2006) Dietary a-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev 19, 26–52.
102 Hibbeln JR & Davis JM (2009) Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins, Leukot Essent Fatty Acids 81, 179–186.
103 Willett WC (2007) The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med (Hagerstown) 8, Suppl. 1, S42–S45.
104 Calder PA (2010) The American Heart Association advisory on n-6 fatty acids: evidence based or biased evidence? Br J Nutr 104, 1575–1576.
105 Mozaffarian D & Willett WC (2007) Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep 9, 486–493.
106 Mozaffarian D & Clarke R (2009) Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63, 522–533.
107 Ascherio A & Willet W (1997) Health effects of trans fatty acids. Am J Clin Nutr 66, Suppl, 1006S–1010S.
108 Eckel RH (2007) Understanding the Complexity of Trans Fatty Acid Reduction in the American Diet: American Heart Association Trans Fat Conference 2006: Report of the Trans Fat Conference Planning Group. Circulation 115, 2231–2246.
109 Marcanson W (2006) How Many Grams of Trans-Fat Are Recommended per Day? J Am Diet Assoc 106, 1507.
110 Fernandez ML & Calle M (2010) Revisiting Dietary Cholesterol Recommendations: Does the Evidence Support a Limit of 300 mg/d? Curr Atheroscler Rep 12, 377–383.